A vial of the Covid-19 vaccine produced by Pfizer and BioNTech. | Justin Tallis/Getty Images

The deal would get the US a little closer to its vaccine goals.

The Trump administration is nearing a deal to procure tens of millions more Covid-19 vaccine doses from the pharmaceutical company Pfizer, Sharon LaFraniere and Katie Thomas reported for the New York Times on Tuesday.

The deal would reportedly give Pfizer, through a government directive, better access to supplies it needs to manufacture more vaccine doses. Pfizer would then leverage those supplies to pump out much-needed vaccines to Americans, helping fill gaps the country faces in the coming months as the vaccine process gets underway.

If successful, the deal could produce up to 100 million additional doses from April through June. That’d be enough to cover 50 million Americans, because the vaccine requires two doses